Skip to main content
50°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alpine Immune Sciences Inc
(NQ:
ALPN
)
38.76
+0.11 (+0.28%)
Streaming Delayed Price
Updated: 11:07 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alpine Immune Sciences Inc
< Previous
1
2
3
4
5
6
Next >
Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
March 21, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
March 20, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Analysts Boost Their Forecasts After Q4 Earnings
March 19, 2024
Alpine Immune Sciences, Inc. (NASDAQ: ALPN) reported better-than-expected fourth-quarter financial results.
Via
Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 3/19
March 19, 2024
Via
Investor Brand Network
Evaluating Alpine Immune Sciences: Insights From 6 Financial Analysts
March 19, 2024
Via
Benzinga
Recap: Alpine Immune Sciences Q4 Earnings
March 18, 2024
Via
Benzinga
Preview: Alpine Immune Sciences's Earnings
March 15, 2024
Via
Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 3/8
March 08, 2024
Via
Investor Brand Network
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.
Via
Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 2/29
February 29, 2024
Via
Investor Brand Network
In-Depth Examination Of 6 Analyst Recommendations For Alpine Immune Sciences
January 26, 2024
Via
Benzinga
Beyond The Numbers: 7 Analysts Discuss Alpine Immune Sciences Stock
December 22, 2023
Via
Benzinga
ALPN Stock Earnings: Alpine Immune Sciences Beats EPS, Beats Revenue for Q4 2023
March 18, 2024
ALPN stock results show that Alpine Immune Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
March 18, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Earnings Scheduled For March 18, 2024
March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
The Latest Analyst Ratings for Alpine Immune Sciences
November 15, 2023
Via
Benzinga
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
February 26, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
February 01, 2024
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alaska Air Posts Upbeat Earnings, Joins Xerox, United Rentals And Other Big Stocks Moving Higher On Thursday
January 25, 2024
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Shares of Alaska Air Group, Inc. (NYSE: ALK) rose during Thursday’s session following upbeat earnings.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 25, 2024
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
Via
Benzinga
Tesla To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Friday
December 22, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie
December 21, 2023
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 18, 2023
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences to Participate in the Evercore ISI HealthconX Conference
November 20, 2023
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Presents New Translational Data on Povetacicept in Systemic Lupus Erythematosus at American College of Rheumatology Convergence 2023
November 15, 2023
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Reports Third Quarter 2023 Financial Results
November 14, 2023
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Alpine Immune Sciences Presents New Translational Data on Acazicolcept in Systemic Lupus Erythematosus at American College of Rheumatology Convergence 2023
November 13, 2023
From
Alpine Immune Sciences, Inc.
Via
Business Wire
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 07, 2023
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.